Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 1 3 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 26 Prostatic Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Nasopharyngeal Neoplasms 6 Head and Neck Neoplasms 6 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Oropharyngeal Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Radiation Injuries 2 Neurotoxicity Syndromes 2 Hypopharyngeal Neoplasms 2 Glioblastoma 2 Carcinoma 2 Brain Neoplasms 2 Astrocytoma 2 Vaginal Neoplasms 1 Thoracic Neoplasms 1 Stage II Prostate Adenocarcinoma AJCC v7 1 Sarcoma 1 Precancerous Conditions 1 Postoperative Complications 1 Papillomavirus Infections 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Adenocarcinoma 1 Ototoxicity 1 Oligodendroglioma 1

Interventions

Paclitaxel 20 Gemcitabine 16 Dexamethasone 16 Bevacizumab 16 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Fluorouracil 11 Leucovorin 10 Cisplatin 10 pembrolizumab 9 Pemetrexed 9 Epoetin Alfa 9 venetoclax 8 Prednisone 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 atezolizumab 7 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

NCT01403779 2022-11-07

KOSIMA

Universitätsmedizin Mannheim

Phase 3 Completed

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡